MARKET

SNYNF

SNYNF

Sanofi FR
OTCPK
93.50
NaN%
Closed 09:30 04/15 EDT
OPEN
--
PREV CLOSE
93.50
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
107.08
52 WEEK LOW
90.00
MARKET CAP
112.90B
P/E (TTM)
12.50
1D
5D
1M
3M
1Y
5Y
1D
Protalix: Elfabrio Struggles Against Oral Competition
Seeking Alpha · 13h ago
White House reportedly eyeing former deputy surgeon general to lead CDC
Seeking Alpha · 20h ago
Kymera: 'Strong Buy' On Continued Success With KT-621 In Th2-Driven Disorders
Seeking Alpha · 2d ago
Sanofi price target raised to EUR 82 from EUR 80 at Citi
TipRanks · 2d ago
Regeneron And Sanofi's Dupixent Gets EC Approval To Treat Children Aged 2-11 Years With CSU
NASDAQ · 2d ago
Weekly Report: what happened at SNYNF last week (0406-0410)?
Weekly Report · 2d ago
Regeneron, Sanofi announce European Commission approval for Dupixent indication
TipRanks · 2d ago
Regeneron, Sanofi Secure EU Nod To Expand Dupixent Use In Young Children With CSU
NASDAQ · 3d ago
More
About SNYNF
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Webull offers Sanofi SA stock information, including OTCPK: SNYNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNYNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNYNF stock methods without spending real money on the virtual paper trading platform.